Concord Drugs has informed that it enclosed newspaper clippings as per Regulation 47(1)(b) read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, published in Financial Express (English) and Nava Telangana (Telugu) on Wednesday, the August 16, 2023 in respect of unaudited financial results for quarter ended 30.06.2023.
The above information is a part of company’s filings submitted to BSE.